Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Aug 2014 15:36

RNS Number : 6618P
Circassia Pharmaceuticals Plc
20 August 2014
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Circassia Pharmaceuticals Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

ODEY ASSET MANAGEMENT LLP

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

19 AUGUST 2014

6. Date on which issuer notified:

 20 AUGUST 2014

7. Threshold(s) that is/are crossed orreached: vi, vii

9%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Share

(GB00BJVD3B28)

17,282,975

17,282,975

16,516,301

16,516,301

8.72%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

Ordinary Shares

8.72%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

All Odey funds hold less than 3%.

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Shermin Goodluck

15. Contact telephone number:

01865 405560

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUROSRSSAWUAR
Date   Source Headline
27th Jan 202011:47 amRNSHolding(s) in Company
21st Jan 20201:46 pmRNSHolding(s) in Company
17th Jan 20203:34 pmRNSHolding(s) in Company
15th Jan 20202:22 pmRNSHolding(s) in Company
13th Jan 20203:13 pmRNSHolding(s) in Company
10th Jan 20205:39 pmRNSHolding(s) in Company
10th Jan 20205:38 pmRNSHolding(s) in Company
10th Jan 20203:18 pmRNSInvestment in Circassia Pharmaceuticals plc
9th Jan 20204:26 pmRNSHolding(s) in Company
9th Jan 20207:00 amRNSCircassia Announces Business Update
3rd Jan 202011:53 amRNSHolding(s) in Company
31st Dec 20197:00 amRNSTotal Voting Rights
19th Dec 20192:03 pmRNSGrant of Options
19th Dec 20197:04 amRNSUpdate on Licensing Agreement with BeyondAir Inc.
17th Dec 201910:50 amRNSHolding(s) in Company
13th Dec 20194:05 pmRNSHolding(s) in Company
6th Dec 201912:25 pmRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSCircassia Announces Board Changes
3rd Dec 20194:33 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSTotal Voting Rights Update
27th Nov 20191:38 pmRNSHolding(s) in Company
26th Nov 20196:03 pmRNSHolding(s) in Company
26th Nov 20194:55 pmRNSHolding(s) in Company
26th Nov 20194:51 pmRNSHolding(s) in Company
25th Nov 20195:38 pmRNSHolding(s) in Company
25th Nov 20195:35 pmRNSHolding(s) in Company
4th Nov 20192:48 pmRNSHolding(s) in Company
31st Oct 20197:00 amRNSTotal Voting Rights Update
21st Oct 20197:00 amRNSUS launch of Duaklir at CHEST 2019
17th Oct 20195:34 pmRNSGrant of options
4th Oct 20194:30 pmRNSHolding(s) in Company
1st Oct 201911:25 amRNSDirector/PDMR Shareholding
30th Sep 201911:06 amRNSTotal Voting Rights
30th Sep 201911:02 amRNSBlock listing Interim Review
26th Sep 20197:00 amRNSInterim Results for Six Months Ended 30 June 2019
20th Sep 20193:37 pmRNSHolding(s) in Company
19th Sep 20195:40 pmRNSHolding(s) in Company
18th Sep 20195:26 pmRNSHolding(s) in Company
18th Sep 20195:21 pmRNSHolding(s) in Company
17th Sep 20191:10 pmRNSHolding(s) in Company
17th Sep 201912:01 pmRNSHolding(s) in Company
16th Sep 20194:51 pmRNSHolding(s) in Company
13th Sep 20195:57 pmRNSBlock listing Interim Review
12th Sep 20197:00 amRNSNotice of Results and Appointment of Joint Broker
30th Aug 20197:00 amRNSTotal Voting Rights
23rd Aug 20195:23 pmRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSAppointment of Jonathan Emms as COO
31st Jul 20191:55 pmRNSTotal Voting Rights
22nd Jul 20194:12 pmRNSHolding(s) in Company
9th Jul 20191:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.